A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult Participants
Status:
Completed
Trial end date:
2019-08-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the effect of itraconazole (Part 1) and rifampin
(Part 2) on the single-dose pharmacokinetics (PK) of TAK-788 and its active metabolites
(AP32960 and AP32914) in healthy adult participants.